| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.34 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |